Cottage Street Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-1,200
Closed -$321K – 90
2020
Q2
$321K Sell
1,200
-300
-20% -$90.2K 0.24% 75
2020
Q1
$475K Sell
1,500
-700
-32% -$212K 0.43% 57
2019
Q4
$653K Buy
2,200
+700
+47% +$194K 0.37% 56
2019
Q3
$349K Buy
+1,500
New +$349K 0.21% 76

Other funds holding BIIB

Cottage Street Advisors's BIIB Position: Q3 2020 in Review

Cottage Street Advisors sold out of Biogen (BIIB) in Q3 2020, closing a stake of 1,200 shares — an estimated $321K sold.

Cottage Street Advisors first reported a position in BIIB in Q3 2019 and held it in 4 quarters. The position peaked at $653K in Q4 2019. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Cottage Street Advisors reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • Cottage Street Advisors sold 1,200 Biogen shares in Q3 2020, an estimated $321K.
  • Cottage Street Advisors first reported a position in Biogen in Q3 2019 and held it in 4 quarters.
  • Cottage Street Advisors's Biogen position peaked at $653K in Q4 2019.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Cottage Street Advisors's 13F filing for Q3 2020, filed 8 Oct 2020.